Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan. This morning, biotherapeutics company aTyr Pharma I...

Gold and the Cracks in the U.S., Japan and Germany’s Economic Data

Talk of a synchronized world - all three economic superpowers are in a recession! The U.S. suffers from industrial recession, Japan from export recession, while Germany may fall into a broad economic recession. Will the gold market warm up to these news? Recent U.S. Da...

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. Immuno-pharmaceutical company AIM Imm...

Biopharma Makes Licensing Deal for Therapeutic Rights in Japan

The company's reasons for the transaction and expected short-term, stock-moving events are provided in a ROTH Capital Partners report. In a Sept. 9 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Eidos Therapeutics Inc. (EIDX:NASDAQ) agreed...

Market News Report: January 20, 2020 – January 24, 2020

Last week has been all about the U.S. - China trade war deal signing. The markets went almost full-on risk-on on that news. But there were more quite interesting developments, i.e. Thursday’s Euro decline. Will the coming week bring some interesting news events...

Seabed rare earth and precious metal mining

Rising prices in precious metals and China’s monopoly in rare earth elements are leading to creativity and innovation in mining. For instance, Japan reported last month that they found extremely rich deposits of rare earth minerals on the seabed of the Pa...

A huge LNG energy boom has begun

Oh, the law of unintended consequences and the opportunities it brings. Thanks to the new standard of Keynesian Abenomics, the Nikkei has blasted 47% higher since November. The Yen has lost about 25% against the U.S. dollar in the same time. While we don't know what the ...

Market News Report: December 16 – December 20, 2019

The markets were pretty quiet early last week ahead of Wednesday’s FOMC Rate Decision announcement. But it didn’t move them that much. All changed on Thursday following Donald Trump’s tweet about the coming trade deal. It set the...

Smart Gold Investors Ask: Crisis or Zombification?

Many people worry about the replay of the last economic crisis . But what if we look not in the direction from which the threat will come? What if we fight the last war? We invite you to read our today’s article about the possibility that the endgame will not ...

Daily Gold News: Monday, June 15 – Gold Bouncing Off $1,750 Resistance Level Again

The gold futures contract lost 0.14% on Friday, as it remained within its Thursday’s daily trading range. The price broke above $1,750 mark once again before closing below that resistance level. Global markets went risk-on and gold has been selling off as a ...
1 2 3 4 5 6 7 8 9 10 ...